Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer

Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts

(2019) Mark A. Eckert et al.   NATURE

Glucose deprivation elicits phenotypic plasticity via ZEB1-mediated expression of NNMT

(2017) Justyna Kanska et al.   Oncotarget

NNMT Silencing Activates Tumor Suppressor PP2A, Inactivates Oncogenic STKs, and Inhibits Tumor Forming Ability

(2016) Kamalakannan Palanichamy et al.   CLINICAL CANCER RESEARCH

Identification and Characterization of Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma Cell Lines

(2015) Valentina Pozzi et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer

(2015) C. J. Whatcott et al.   CLINICAL CANCER RESEARCH

Molecular mechanisms of epithelial–mesenchymal transition

(2014) Samy Lamouille et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: A prospective analysis

(2013) Vanessa L. Beesley et al.   GYNECOLOGIC ONCOLOGY

Staging classification for cancer of the ovary, fallopian tube, and peritoneum

(2013) Jaime Prat et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink

(2013) Olesya A Ulanovskaya et al.   Nature Chemical Biology

Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis

(2009) Jongmin Kim et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

(2008) R. W. Tothill et al.   CLINICAL CANCER RESEARCH